PRIMARY HYPERPARATHYROIDISM - INCIDENCE OF CARDIAC ABNORMALITIES AND PARTIAL REVERSIBILITY AFTER SUCCESSFUL PARATHYROIDECTOMY

被引:153
作者
STEFENELLI, T
MAYR, H
BERGLERKLEIN, J
GLOBITS, S
WOLOSZCZUK, W
NIEDERLE, B
机构
[1] UNIV VIENNA,LUDWIG BOLTZMANN INST CLIN ENDOCRINOL,A-1010 VIENNA,AUSTRIA
[2] UNIV VIENNA,DEPT HOP CANTONAL,A-1010 VIENNA,AUSTRIA
[3] UNIV VIENNA,DEPT SURG 1,A-1010 VIENNA,AUSTRIA
关键词
D O I
10.1016/0002-9343(93)90260-V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: This prospective study was designed to assess the effect of primary hyperparathyroidism on heart muscle, valves, and myocardial function. Echocardiography was used to evaluate changes in mechanical performance, the thickness of the left ventricular wall, myocardial calcific deposits, and valvular calcifications in patients with primary hyperparathyroidism. METHODS: Echocardiography was performed in 54 patients with hyperparathyroidism prior to surgery and 12 +/- 2 months after successful parathyroidectomy. A matched control group was followed for comparison. RESULTS: In a blinded fashion, aortic and mitral valve calcifications were detected in 63% and 49% of patients with primary hyperparathyroidism (controls: 12% and 15%, respectively). Calcific deposits in the myocardium were found in 69% of patients with hyperparathyroidism and 17% of the control subjects. After parathyroidectomy and 12 months of normocalcemia, a significant regression of left ventricular hypertrophy (p < 0.001) was observed. CONCLUSIONS. The present data show a high incidence of left ventricular hypertrophy, calcific deposits in the myocardium, and/or aortic and mitral valve calcification in patients with primary hyperparathyroidism. A 1-year follow-up after parathyroidectomy (and restoration of normocalcemia) discloses regression of hypertrophy, while calcifications persist without evidence of progression.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 38 条
[1]   REVERSION OF CARDIAC-HYPERTROPHY AND REDUCED ARTERIAL COMPLIANCE AFTER CONVERTING ENZYME-INHIBITION IN ESSENTIAL-HYPERTENSION [J].
ASMAR, RG ;
PANNIER, B ;
SANTONI, JP ;
LAURENT, S ;
LONDON, GM ;
LEVY, BI ;
SAFAR, ME .
CIRCULATION, 1988, 78 (04) :941-950
[2]  
BRADLEY JR, 1985, LANCET, V2, P1370
[3]   CALCIFIC DEPOSITS IN THE HEART [J].
CATELLIER, MJ ;
CHUA, GT ;
YOUMANS, G ;
WALLER, BF .
CLINICAL CARDIOLOGY, 1990, 13 (04) :287-294
[4]  
DAVIDSON RC, 1967, T AM SOC ART INT ORG, V13, P36
[5]  
DIAMOND TH, 1987, S AFR MED J, V71, P448
[6]   EVALUATION OF LEFT VENTRICULAR FUNCTION BY ECHOCARDIOGRAPHY [J].
FORTUIN, NJ ;
CRAIGE, E ;
HOOD, WP .
CIRCULATION, 1972, 46 (01) :26-&
[7]  
GISINGER C, 1985, PLASMA THER TRANSFUS, V6, P547
[8]  
GLOGAR D, 1980, DEUT MED WOCHENSCHR, V105, P1
[9]   LEFT-VENTRICULAR HYPERTROPHY IN END-STAGE RENAL-DISEASE [J].
HARNETT, JD ;
PARFREY, PS ;
GRIFFITHS, SM ;
GAULT, MH ;
BARRE, P ;
GUTTMANN, RD .
NEPHRON, 1988, 48 (02) :107-115
[10]   PRIMARY HYPER-PARATHYROIDISM - INCIDENCE, MORBIDITY, AND POTENTIAL ECONOMIC-IMPACT IN A COMMUNITY [J].
HEATH, H ;
HODGSON, SF ;
KENNEDY, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (04) :189-193